차영 (McLean Hospital/Harvard Medical School)님 | 한빛사연구자 > 한빛사

McLean Hospital/Harvard Medical School

최종업데이트 2025.02.17.

Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s disease
- Cell Stem Cell, February 13, 2025 | https://doi.org/10.1016/j.stem.2025.01.006
- 2025-02
- 생명과학
- 한빛사논문
SIRT2 regulates mitochondrial dynamics and reprogramming via MEK1-ERK-DRP1 and AKT1-DRP1 axes
- Cell Reports, Volume 37, Issue 13, 28 December 2021, 110155 | https://doi.org/10.1016/j.celrep.2021.110155
- 2021-12
- 생명과학
- 한빛사논문
Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models
- J. Clin. Invest., Published: January 13, 2020 | https://doi.org/10.1172/JCI130767
- 2020-01
- 생명과학
- 한빛사논문
Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c–SIRT2 axis
- Nat. Cell Biol., 2017 May;19(5):445-456, doi:10.1038/ncb3517
- 2017-05
- 생명과학
- 한빛사논문, 상위피인용논문

연구자 ID

저자논문